{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:32:09Z","timestamp":1785879129413,"version":"3.56.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006981","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000}}],"reference-count":40,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006981.pub2","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T16:51:52Z","timestamp":1305132712000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis"],"prefix":"10.1002","author":[{"given":"Carolyn A","family":"Young","sequence":"first","affiliation":[{"name":"The Walton Centre for Neurology and Neurosurgery; Lower Lane Fazakerley Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Ellis","sequence":"additional","affiliation":[{"name":"Academic Neurosciences Centre, King's College Hospital; Motor Nerve Clinic; Denmark Hill London UK SE5 9RS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Johnson","sequence":"additional","affiliation":[{"name":"King's College Hospital; Speech and Language Therapy Department; Denmark Hill London UK SE5 9RS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Sathasivam","sequence":"additional","affiliation":[{"name":"The Walton Centre for Neurology and Neurosurgery; Neurology Department; Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Pih","sequence":"additional","affiliation":[{"name":"Neuro Rehabilitation Unit; Research Office; The Walton Centre for Neurology Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD006981.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle and Nerve"},{"issue":"1-2","key":"10.1002\/14651858.CD006981.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-510X(01)00631-1","article-title":"External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis","volume":"191","author":"Andersen","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Bhatia KP M\u00fcnchau A Brown P Botulinum toxin is a useful treatment in excessive drooling in saliva Journal of Neurology, Neurosurgery and Psychiatry 1999 697","DOI":"10.1136\/jnnp.67.5.697"},{"issue":"5","key":"10.1002\/14651858.CD006981.pub2-BIB0004|cit4","first-page":"280","article-title":"Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands","volume":"18","author":"Carod Artal","year":"2003","journal-title":"Neurologia"},{"issue":"5","key":"10.1002\/14651858.CD006981.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.parkreldis.2006.05.005","article-title":"Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease","volume":"13","author":"Contarino","year":"2007","journal-title":"Parkinsonism and Related Disorders"},{"issue":"4","key":"10.1002\/14651858.CD006981.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00415-008-0738-5","article-title":"Botulinum toxin type-B improves sialorrhea and quality of life in bulbar onset amyotrophic lateral sclerosis","volume":"255","author":"Costa","year":"2008","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006981.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.69.1.121","article-title":"Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis","volume":"69","author":"Giess","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006981.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"359-63","DOI":"10.3109\/17482960903264998","article-title":"Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study","volume":"11","author":"Gilio","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"4","key":"10.1002\/14651858.CD006981.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2310\/7070.2001.19779","article-title":"Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis","volume":"30","author":"Harriman","year":"2001","journal-title":"The Journal of Otolaryngology"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0010|cit10","first-page":"A99","article-title":"The Spectrum of Patient Symptoms in ALS and Symptom Management","volume":"8 Suppl 3","author":"Heiman-Patterson","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD006981.pub2-BIB0011|cit11","first-page":"19","article-title":"Pharmacological therapy of sialorrhea in patients with motor neuron disease","volume":"105","author":"Levitskii","year":"2005","journal-title":"Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova"},{"issue":"9","key":"10.1002\/14651858.CD006981.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD006981.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1808-8694(15)31258-1","article-title":"Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis","volume":"71","author":"Manrique","year":"2005","journal-title":"Brazilian Journal of Otorhinolaryngology"},{"issue":"12","key":"10.1002\/14651858.CD006981.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1468-1331.2007.01983.x","article-title":"Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis","volume":"14","author":"Neppelberg","year":"2007","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0022-510X(96)00104-9","article-title":"The control of oral secretions in bulbar ALS\/MND","volume":"139 Suppl","author":"Newall","year":"1996","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD006981.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","article-title":"Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders","volume":"70","author":"Porta","year":"2001","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006981.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.cnd.0000188865.88167.62","article-title":"Parotid gland injections of botulinum toxin a are effective in treating sialorrhea in amyotrophic lateral sclerosis","volume":"7","author":"Scott","year":"2005","journal-title":"journal of Clinical Neuromuscular Disease"},{"issue":"8","key":"10.1002\/14651858.CD006981.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.58.8.1308","article-title":"Results of radiotherapy for drooling in amyotrophic lateral sclerosis","volume":"58","author":"Stalpers","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006981.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20545","article-title":"Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis","volume":"34","author":"Verma","year":"2006","journal-title":"Muscle and Nerve"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Winterholler MG Erbguth FJ Wolf S Kat S Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach Journal of Neurology, Neurosurgery, and Psychiatry 2001 417 8","DOI":"10.1136\/jnnp.70.3.417"},{"issue":"1-2","key":"10.1002\/14651858.CD006981.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000108917","article-title":"Amyotrophic Lateral Sclerosis in South-East England: A Population based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry)","volume":"29","author":"Abhinav","year":"2007\u00a0","journal-title":"Neuroepidemiology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006981.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/PL00007719","article-title":"Palliative care in amyotrophic lateral sclerosis","volume":"244","author":"Borasio","year":"1997","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD006981.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"1-2","key":"10.1002\/14651858.CD006981.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction","volume":"109","author":"Burgen","year":"1949","journal-title":"Journal of Physiology"},{"issue":"4","key":"10.1002\/14651858.CD006981.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0306-9877(97)90103-1","article-title":"Sialorrhoea in amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glands","volume":"48","author":"Bushara","year":"1997","journal-title":"Medical Hypotheses"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"1","key":"10.1002\/14651858.CD006981.pub2-BIB0027|cit27","first-page":"41","article-title":"Otolaryngologic manifestations of amyotrophic lateral sclerosis","volume":"17","author":"Janzen","year":"1988","journal-title":"The Journal of Otolaryngology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006981.pub2-BIB0028|cit28","first-page":"iv32","article-title":"The management of motor neurone disease","volume":"74","author":"Leigh","year":"2003","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/13682820109177898","article-title":"Drooling in Parkinson's disease: a novel speech and language therapy intervention","volume":"36 Suppl","author":"Marks","year":"2001","journal-title":"International Journal of Language and Communication Disorders"},{"issue":"5","key":"10.1002\/14651858.CD006981.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/WNL.46.5.1442","article-title":"Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV\/CNTF ALS Study Group","volume":"46","author":"McGuire","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006981.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tripleo.2005.08.018","article-title":"Drooling of saliva: a review of the etiology and management options","volume":"101","author":"Meningaud","year":"2006","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics"},{"issue":"7","key":"10.1002\/14651858.CD006981.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1212\/WNL.52.7.1311","article-title":"Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force","volume":"52","author":"Miller","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006981.pub2-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006981.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14660820310011728","article-title":"Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction","volume":"4","author":"Mitsomoto","year":"2003","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-510X(96)00087-1","article-title":"The quality of care and symptom control - the effects on the terminal phase of ALS\/MND","volume":"139 Suppl","author":"Oliver","year":"1996","journal-title":"Journal of the Neurological Sciences"},{"issue":"22","key":"10.1002\/14651858.CD006981.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006981.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2273.1985.tb01171.x","article-title":"Reversibility of reduced mucociliary clearance in chronic sinusitis","volume":"10","author":"Sakakura","year":"1985","journal-title":"Clinical Otolaryngology and Allied Sciences"},{"issue":"7191","key":"10.1002\/14651858.CD006981.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.318.7191.1118","article-title":"Motor neurone disease","volume":"318","author":"Shaw","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006981.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Veis S Salivary flow in persons with ALS 11th International Symposium on ALS\/MND, Aarhus, Denmark (Poster) 2000","DOI":"10.1080\/09699260.2001.11746898"},{"issue":"1-2","key":"10.1002\/14651858.CD006981.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(01)00630-X","article-title":"The epidemiology of motor neuron diseases: a review of recent studies","volume":"191","author":"Worms","year":"2001","journal-title":"Journal of the Neurological Sciences"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006981.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006981.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:05:58Z","timestamp":1628546758000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006981.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006981.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006981.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]}}}